Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Ader

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2009
Management of invasive aspergillosis in patients with COPD: rational use of voriconazoleFlorence Ader, Anne-Lise Bienvenu, Blandine Rammaert, et al.
Frontiers in Medicine|October 3, 2022
Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome predictionOlivier Bahuaud, Charlotte Genestet, Jonathan Hoffmann, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2018
Comment on: MIC-based dose adjustment: facts and fablesSylvain Goutelle, Charlotte Genestet, Florence Ader, et al.
Medecine Sciences : M/S|July 19, 2012
[Legionella, Legionnaires' disease]Yvan Jamilloux, Sophie Jarraud, Gérard Lina, et al.
The Pediatric Infectious Disease Journal|July 24, 2019
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and LevofloxacinAnnabelle Huguet, Florence Ader, Camille Ohlmann, et al.
The Lancet. Infectious Diseases|November 28, 2021
Assessing the evidence on remdesivirMarius Trøseid, Maya Hites, Andreas Barratt-Due, et al.
Bulletin Du Cancer|May 8, 2019
[Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors]Vincent Alcazer, Régis Peffault de Latour, Florence Ader, et al.
Expert Review of Anti-Infective Therapy|July 15, 2022
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to loseDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2022
B-cell malignancies and COVID-19: a narrative reviewDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Infectious Disease Clinics of North America|February 5, 2017
Legionnaire's Disease in Compromised HostsFanny Lanternier, Florence Ader, Benoit Pilmis, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2009
Management of invasive aspergillosis in patients with COPD: rational use of voriconazoleFlorence Ader, Anne-Lise Bienvenu, Blandine Rammaert, et al.
Frontiers in Medicine|October 3, 2022
Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome predictionOlivier Bahuaud, Charlotte Genestet, Jonathan Hoffmann, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2018
Comment on: MIC-based dose adjustment: facts and fablesSylvain Goutelle, Charlotte Genestet, Florence Ader, et al.
Medecine Sciences : M/S|July 19, 2012
[Legionella, Legionnaires' disease]Yvan Jamilloux, Sophie Jarraud, Gérard Lina, et al.
The Pediatric Infectious Disease Journal|July 24, 2019
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and LevofloxacinAnnabelle Huguet, Florence Ader, Camille Ohlmann, et al.
The Lancet. Infectious Diseases|November 28, 2021
Assessing the evidence on remdesivirMarius Trøseid, Maya Hites, Andreas Barratt-Due, et al.
Bulletin Du Cancer|May 8, 2019
[Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors]Vincent Alcazer, Régis Peffault de Latour, Florence Ader, et al.
Expert Review of Anti-Infective Therapy|July 15, 2022
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to loseDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2022
B-cell malignancies and COVID-19: a narrative reviewDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Infectious Disease Clinics of North America|February 5, 2017
Legionnaire's Disease in Compromised HostsFanny Lanternier, Florence Ader, Benoit Pilmis, et al.
Pageof 17